These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 29704490)
21. Vasa vasorum in plaque angiogenesis, metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: a malignant transformation. Hayden MR; Tyagi SC Cardiovasc Diabetol; 2004 Feb; 3():1. PubMed ID: 14761253 [TBL] [Abstract][Full Text] [Related]
22. Mathematical modeling of plaque progression and associated microenvironment: How far from predicting the fate of atherosclerosis? Cai Y; Li Z Comput Methods Programs Biomed; 2021 Nov; 211():106435. PubMed ID: 34619601 [TBL] [Abstract][Full Text] [Related]
23. Angiogenesis as risk factor for plaque vulnerability. Di Stefano R; Felice F; Balbarini A Curr Pharm Des; 2009; 15(10):1095-106. PubMed ID: 19355951 [TBL] [Abstract][Full Text] [Related]
27. Elimination of neoangiogenesis for plaque stabilization: is there a role for local drug therapy? Kolodgie FD; Narula J; Yuan C; Burke AP; Finn AV; Virmani R J Am Coll Cardiol; 2007 May; 49(21):2093-101. PubMed ID: 17531658 [TBL] [Abstract][Full Text] [Related]
28. Vasa vasorum and plaque neovascularization on contrast-enhanced carotid ultrasound imaging correlates with cardiovascular disease and past cardiovascular events. Staub D; Patel MB; Tibrewala A; Ludden D; Johnson M; Espinosa P; Coll B; Jaeger KA; Feinstein SB Stroke; 2010 Jan; 41(1):41-7. PubMed ID: 19910551 [TBL] [Abstract][Full Text] [Related]
29. Intraplaque hemorrhage in cardiac allograft vasculopathy. Castellani C; Angelini A; de Boer OJ; van der Loos CM; Fedrigo M; Frigo AC; Meijer-Jorna LB; Li X; Ploegmakers HJ; Tona F; Feltrin G; Gerosa G; Valente M; Thiene G; van der Wal AC Am J Transplant; 2014 Jan; 14(1):184-92. PubMed ID: 24354875 [TBL] [Abstract][Full Text] [Related]
30. Pathology of human plaque vulnerability: mechanisms and consequences of intraplaque haemorrhages. Michel JB; Martin-Ventura JL; Nicoletti A; Ho-Tin-Noé B Atherosclerosis; 2014 Jun; 234(2):311-9. PubMed ID: 24726899 [TBL] [Abstract][Full Text] [Related]
31. Intraplaque neovascularization and hemorrhage: markers for cardiovascular risk stratification and therapeutic monitoring. Koole D; Heyligers J; Moll FL; Pasterkamp G J Cardiovasc Med (Hagerstown); 2012 Oct; 13(10):635-9. PubMed ID: 22955205 [TBL] [Abstract][Full Text] [Related]
32. Angiogenesis Inhibitor, Endostar, Prevents Vasa Vasorum Neovascularization in a Swine Atherosclerosis Model. Xu X; Mao W; Chai Y; Dai J; Chen Q; Wang L; Zhuang Q; Pan Y; Chen M; Ni G; Huang Z J Atheroscler Thromb; 2015; 22(10):1100-12. PubMed ID: 26016418 [TBL] [Abstract][Full Text] [Related]
33. Segmental heterogeneity of vasa vasorum neovascularization in human coronary atherosclerosis. Gössl M; Versari D; Hildebrandt HA; Bajanowski T; Sangiorgi G; Erbel R; Ritman EL; Lerman LO; Lerman A JACC Cardiovasc Imaging; 2010 Jan; 3(1):32-40. PubMed ID: 20129528 [TBL] [Abstract][Full Text] [Related]
34. An integrated approach to simulating the vulnerable atherosclerotic plaque. Mohammad Mirzaei N; Weintraub WS; Fok PW Am J Physiol Heart Circ Physiol; 2020 Oct; 319(4):H835-H846. PubMed ID: 32795179 [TBL] [Abstract][Full Text] [Related]
35. Phosphorylcholine Monoclonal Antibody Therapy Decreases Intraplaque Angiogenesis and Intraplaque Hemorrhage in Murine Vein Grafts. Baganha F; Sluiter TJ; de Jong RCM; van Alst LA; Peters HAB; Jukema JW; Delibegovic M; Pettersson K; Quax PHA; de Vries MR Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362449 [TBL] [Abstract][Full Text] [Related]